Ocugen, Inc.
OCGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,752 | $1,373 | $1,481 | $764 |
| % Growth | 27.6% | -7.3% | 93.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1,752 | $1,373 | $1,481 | $764 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $11,149 | $8,403 | $9,529 | $8,290 |
| G&A Expenses | $8,228 | $6,765 | $6,453 | $6,314 |
| SG&A Expenses | $8,228 | $6,765 | $6,453 | $6,314 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,377 | $15,168 | $15,982 | $14,604 |
| Operating Income | -$17,625 | -$13,795 | -$14,501 | -$13,840 |
| % Margin | -1,006% | -1,004.7% | -979.1% | -1,811.5% |
| Other Income/Exp. Net | -$2,426 | -$944 | -$849 | -$40 |
| Pre-Tax Income | -$20,051 | -$14,739 | -$15,350 | -$13,880 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20,051 | -$14,739 | -$15,350 | -$13,880 |
| % Margin | -1,144.5% | -1,073.5% | -1,036.5% | -1,816.8% |
| EPS | -0.066 | -0.051 | -0.053 | -0.048 |
| % Growth | -30.7% | 4% | -10.3% | – |
| EPS Diluted | -0.066 | -0.051 | -0.053 | -0.048 |
| Weighted Avg Shares Out | 304,003 | 292,032 | 291,997 | 290,925 |
| Weighted Avg Shares Out Dil | 304,003 | 292,032 | 291,997 | 290,925 |
| Supplemental Information | – | – | – | – |
| Interest Income | $207 | $0 | $0 | $0 |
| Interest Expense | $1,314 | $1,058 | $914 | $0 |
| Depreciation & Amortization | $950 | $927 | $909 | $598 |
| EBITDA | -$17,787 | -$12,868 | -$13,592 | -$13,242 |
| % Margin | -1,015.2% | -937.2% | -917.8% | -1,733.2% |